Featured
Spotlight on Autoimmunity: Potential New Frontiers in the Treatment of Lupus Nephritis
Watch Time: 05:01
Learn about current management of lupus nephritis and how current clinical trials are evaluating novel therapeutic approaches to address unmet needs in the treatment of lupus nephritis.
Key Publications
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
Fischbach F, et al.
Med. Published online March 29, 2024
First Two US Patients With Lupus Nephritis (LN) Treated With Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy: Preliminary Results From the KYSA-1 Phase 1/2, Multicenter Study of KYV-101
Podoll A, et al.
14th European Lupus Meeting, 2024
Anti-CD19 CAR T cells for refractory myasthenia gravis
Haghikia A, et al.
Lancet Neurology 2023;22:P1104-1105
KYV-101, a Fully Human Anti-CD19 CAR T Cell Therapy, Demonstrates CAR-Mediated and CD19-Dependent Activity Against Autologous B Cells from Patients with Autoimmune Disease
Park S, et al.
ACR Convergence 2023, Abstract #0904
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen A, et al.
Nat Med 2022;28:2424-2132
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
Brudno JN, et al.
Nat Med 2020;26:270-280
Meet Kyverna
June 12 – 15, 2024
Vienna, Austria
The European Congress of Rheumatology provides a forum of the highest standard for scientific (both clinical and basic), educational, and social exchange between professionals involved in rheumatology, liaising with patient organizations, in order to achieve progress in the clinical care of people with rheumatic diseases.
June 29 – July 2, 2024
Helsinki, Finland
This year’s overarching theme is ‘Neuromodulation: advances and opportunities in neurological diseases’ and there will be a range of workshops and plenary sessions addressing this subject. Leading specialists will tackle hot topics in invasive and non-invasive neuromodulation in movement and cognitive disorders, chronic pain, and refractory epilepsy.
September 18 - 20, 2024
Copenhagen, Denmark
ECTRIMS 2024 is the premier meeting place for researchers, clinicians, and healthcare providers to collaborate on the next life-changing research and treatment options for people with MS and related diseases.
Educational Videos
Watch Time: 09:45
Learn more about the current strategies for the management of lupus nephritis, from meticulous control of blood pressure, inflammation, to ensure that comprehensive care is kept in the picture to account for patient lifestyle and preference.
Watch Time: 10:56
Nicole was diagnosed with myasthenia gravis in 2016. This is her journey to CAR T-cell therapy.